# My Scrivener® - Measuring Effectiveness and Dose Response in Children

> **NCT00919906** · PHASE1,PHASE2 · COMPLETED · sponsor: **Obslap Research LLC** · enrollment: 176 (estimated)

## Conditions studied

- Asperger's Syndrome
- Dyslexia
- Cerebral Palsy
- Attention Deficit Disorder
- ADHD
- Traumatic Brain Injury
- Stroke

## Interventions

- **DEVICE:** My Scrivener(R)

## Key facts

- **NCT ID:** NCT00919906
- **Lead sponsor:** Obslap Research LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2010-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919906, "My Scrivener® - Measuring Effectiveness and Dose Response in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00919906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*